解郁通窍方联合头颅针治疗卒中后抑郁疗效观察及对血清Apelin-13、Claudin-5 水平的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R255.2;R749.1+3

基金项目:

浙江省中医药科技计划项目(2026ZL0860)


Observation on the Efficacy of Jieyu Tongqiao Prescription Combined with Scalp Acupuncture in the Treatment of Post-Stroke Depression and Its Effects on Serum Levels of Apelin-13 and Claudin-5
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的: 观察解郁通窍方联合头颅针治疗卒中后抑郁(PSD) 的临床疗效及对血清爱帕琳肽-13 (Apelin-13)、紧密连接蛋白-5 (Claudin-5) 水平的影响。方法:选择嘉兴市中医医院2024 年1—12 月收治的120 例PSD 患者,按随机数字表法分为针药联合组和对照组各60 例。治疗过程中对照组脱落4 例,最终纳入56例;针药联合组脱落6例,最终纳入54例。2组均行脑卒中常规治疗,对照组加用头颅针治疗,针药联合组在对照组的基础上加用解郁通窍方治疗。3个月后评价2组临床疗效,比较2组神经功能缺损评分(NIHSS)、汉密尔顿抑郁量表-17 (HAMD-17) 评分、匹兹堡睡眠质量指数(PSQI) 评分,眼动特征(REM睡眠潜伏期、REM密度),血清白细胞介素-6(IL-6)、Apelin-13、Claudin-5、皮质醇(COR)、脑源性神经营养因子(BDNF),5-羟色胺(5-HT) 水平及安全性。结果:治疗后,针药联合组总有效率为90.74%(49/54),对照组为76.79%(43/56),组间比较,差异有统计学意义(P<0.05)。治疗后,2组NIHSS、HAMD-17、PSQI 评分较治疗前降低(P<0.05),且针药联合组NIHSS、HAMD-17、PSQI 评分均低于对照组(P<0.05)。治疗后,2组REM潜伏期均较治疗前延长(P<0.05),REM密度均较治疗前降低(P<0.05);且针药联合组REM潜伏期长于对照组,REM密度低于对照组(P<0.05)。治疗后,2组血清IL-6、COR水平均较治疗前降低(P<0.05),BDNF、5-HT水平均较治疗前升高(P<0.05);且针药联合组IL-6、COR水平低于对照组(P<0.05),BDNF、5-HT水平高于对照组(P<0.05)。治疗后,2组血清Apelin-13、Claudin-5水平均较治疗前升高(P<0.05),且针药联合组Apelin-13、Claudin-5水平高于对照组(P<0.05)。治疗期间,针药联合组不良反应发生率为9.26% (5/54),对照组为12.50% (7/56),2组比较,差异无统计学意义(P>0.05);2组血常规、肝肾功能等均未出现明显异常。结论:解郁通窍方联合头颅针法通过调节神经递质、减轻炎症、修复血脑屏障等多途径改善PSD症状,提高临床疗效。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of Jieyu Tongqiao Prescription combined with scalp acupuncture in the treatment of post-stroke depression (PSD),and to observe its effects on serum levels of Apelin-13 and Claudin-5. Methods: A total of 120 patients with PSD admitted to Jiaxing Hospital of Traditional Chinese Medicine from January to December 2024 were enrolled and randomly divided into the combination group and the control group using the random number table method,with 60 cases in each group. During treatment,4 cases dropped out from the control group and 56 patients were finally included;6 cases dropped out from the combination group and 54 patients were finally included. Both groups received routine stroke treatment. The control group received additional scalp acupuncture,while the combination group received Jieyu Tongqiao Prescription on top of the control group′s regimen. After three months of treatment, the clinical efficacy of the two groups was evaluated. The following parameters were compared between the two groups: National Institutes of Health Stroke Scale (NIHSS) score, Hamilton Depression Scale 17 item version(HAMD-17) score,Pittsburgh Sleep Quality Index (PSQI) score,eye movement features (REM sleep latency, REM density), serum levels of interleukin-6 (IL-6), Apelin-13, Claudin-5, cortisol (COR), brain-derived neurotrophic factor (BDNF), and 5-hydroxytryptamine (5-HT), as well as safety. Results: After treatment, the total effective rate was 90.74% (49/54) in the combination group and 76.79% (43/56) in the control group, with a statistically significant difference between the two groups (P<0.05). After treatment, the scores of NIHSS, HAMD-17, and PSQI decreased significantly in both groups compared with those before treatment (P< 0.05),and the scores of NIHSS,HAMD-17,and PSQI in the combination group were significantly lower than those in the control group (P<0.05). After treatment, REM sleep latency was increased (P<0.05) and REM density was decreased (P<0.05) in both groups compared to before treatment;the combination group showed longer REM latency and lower REM density than the control group (P<0.05). After treatment, serum levels of IL-6 and COR decreased significantly (P<0.05),while levels of BDNF and 5-HT increased significantly (P<0.05) in both groups compared with those before treatment;the combination group showed lower levels of IL-6 and COR (P<0.05) and higher levels of BDNF and 5-HT (P<0.05) than the control group. After treatment, serum levels of Apelin-13 and Claudin-5 increased significantly in both groups compared with those before treatment (P<0.05), and the levels of Apelin-13 and Claudin-5 in the combination group were significantly higher than those in the control group (P<0.05). During treatment, the incidence of adverse reactions was 9.26% (5/54) in the combination group and 12.50% (7/56) in the control group, with no significant difference between the two groups (P>0.05). No obvious abnormalities in routine blood tests or liver/kidney function were observed in either group. Conclusion:Jieyu Tongqiao Prescription combined with scalp acupuncture can improve PSD symptoms and enhance clinical efficacy through multiple pathways,including regulation of neurotransmitters,reduction of inflammation responses,and repair of the blood-brain barrier.

    参考文献
    相似文献
    引证文献
引用本文

周耀诚,吴思静,沈小红,陈崔燕,姚琼,杨喜兵.解郁通窍方联合头颅针治疗卒中后抑郁疗效观察及对血清Apelin-13、Claudin-5 水平的影响[J].新中医,2026,58(18):20-26

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-09-29
  • 出版日期:
文章二维码